NTRR
Neutra Corp.
Price Chart
Latest Quote
$0.00
+0.00 (+0.00%)
Current Price
| Previous Close | $0.00 |
| Open | $0.00 |
| Day High | $0.00 |
| Day Low | $0.00 |
| Volume | 129,500 |
Stock Information
| Shares Outstanding | 2.92B |
| Total Debt | $12K |
| Cash Equivalents | $333 |
| Revenue | $66K |
| Net Income | $-178K |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $292K |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $356K |
| Sales | $66K |
| Income | $-178K |
| Cash/sh | $0.00 |
Financial Ratios
Returns & Margins
| ROA | -398.29% |
| Gross Margin | 64.31% |
| Operating Margin | -47.83% |
| Profit Margin | -269.15% |
Ownership
| Insider Ownership | 0.69% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 4.42 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.00 |
| SMA50 | $0.00 |
| SMA200 | $0.00 |
| RSI | 50.00 |
| ATR | 0.0000 |
| Shares Float | 2.90B |
| Volatility | 46.36 |
| Rel Volume | 0.30 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | -33.33% |
| 6 Months | -33.33% |
| YTD | +0.00% |
| Year | -50.00% |
| 3 Years | -80.00% |
| 5 Years | -97.26% |
| 10 Years | -99.98% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.00 | 285,377 |
| 2026-06-17 | $0.00 | 2,181,993 |
| 2026-06-16 | $0.00 | 1,537,878 |
| 2026-06-15 | $0.00 | 575,876 |
| 2026-06-12 | $0.00 | 100,005 |
| 2026-06-11 | $0.00 | 220,000 |
| 2026-06-10 | $0.00 | 103,299 |
| 2026-06-09 | $0.00 | 0 |
| 2026-06-08 | $0.00 | 0 |
| 2026-06-05 | $0.00 | 42,035 |
| 2026-06-04 | $0.00 | 9,070,705 |
| 2026-06-03 | $0.00 | 905,012 |
| 2026-06-02 | $0.00 | 100,000 |
| 2026-06-01 | $0.00 | 1,010,000 |
| 2026-05-29 | $0.00 | 343,000 |
| 2026-05-28 | $0.00 | 0 |
| 2026-05-27 | $0.00 | 35,033 |
| 2026-05-26 | $0.00 | 0 |
| 2026-05-22 | $0.00 | 10,000 |
| 2026-05-21 | $0.00 | 2,428,950 |
| 2026-05-20 | $0.00 | 0 |
| 2026-05-19 | $0.00 | 14,500,000 |
About Neutra Corp.
Neutra Corp. researches, develops, and provides hemp-derived products in the nutraceutical space in the United States. The company sells hemp-derived products, including products containing delta-8-THC and other cannabinoids, CBD sports creams, and other products. Neutra Corp. was incorporated in 2011 and is based in Houston, Texas.
đ° Latest News
No news articles available at the moment. Check back later for updates on NTRR.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $25,199 | $32,690 | $60,853 |
| Cost Of Revenue | $25,199 | $32,690 | $60,853 |
| Total Revenue | $39,534 | $67,996 | $92,014 |
| Operating Revenue | $39,534 | $67,996 | $92,014 |
| Expenses | |||
| Interest Expense | $3,340 | $62,063 | $60,606 |
| Total Expenses | $269,020 | $365,671 | $675,596 |
| Net Non Operating Interest Income Expense | $-3,340 | $-62,063 | $-60,606 |
| Interest Expense Non Operating | $3,340 | $62,063 | $60,606 |
| Operating Expense | $243,821 | $332,981 | $614,743 |
| Selling And Marketing Expense | $8,459 | $26,101 | $28,476 |
| General And Administrative Expense | $187,123 | $227,974 | $508,482 |
| Other Income Expense | - | $-198,156 | $11,262 |
| Other Non Operating Income Expenses | - | $-198,156 | $11,262 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-233,465 | $-561,417 | $-632,926 |
| Net Interest Income | $-3,340 | $-62,063 | $-60,606 |
| Normalized Income | $-233,465 | $-561,417 | $-644,188 |
| Net Income From Continuing And Discontinued Operation | $-233,465 | $-561,417 | $-632,926 |
| Total Operating Income As Reported | $-229,486 | $-297,675 | $-583,582 |
| Net Income Common Stockholders | $-233,465 | $-576,862 | $-742,188 |
| Net Income | $-233,465 | $-561,417 | $-632,926 |
| Net Income Including Noncontrolling Interests | $-233,465 | $-561,417 | $-632,926 |
| Net Income Continuous Operations | $-233,465 | $-561,417 | $-632,926 |
| Pretax Income | $-232,826 | $-557,894 | $-632,926 |
| Operating Income | $-229,486 | $-297,675 | $-583,582 |
| Depreciation Amortization Depletion Income Statement | $48,239 | $78,906 | $77,785 |
| Depreciation And Amortization In Income Statement | $48,239 | $78,906 | $77,785 |
| Depreciation Income Statement | $48,239 | $78,906 | $77,785 |
| Gross Profit | $14,335 | $35,306 | $31,161 |
| Special Income Charges | - | $0 | $11,262 |
| Per Share | |||
| Diluted EPS | $-0.00 | $-0.00 | $-0.00 |
| Basic EPS | $-0.00 | $-0.00 | $-0.00 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-181,247 | $-416,925 | $-505,797 |
| Reconciled Depreciation | $48,239 | $78,906 | $77,785 |
| EBITDA (Bullshit earnings) | $-181,247 | $-416,925 | $-494,535 |
| EBIT | $-229,486 | $-495,831 | $-572,320 |
| Diluted Average Shares | $2,916,066,065 | $2,230,594,112 | $1,599,716,616 |
| Basic Average Shares | $2,916,066,065 | $2,230,594,112 | $1,599,716,616 |
| Diluted NI Availto Com Stockholders | $-233,465 | $-576,862 | $-742,188 |
| Tax Provision | $639 | $3,523 | $0 |
| Selling General And Administration | $195,582 | $254,075 | $536,958 |
| Other Gand A | $187,123 | $227,974 | $508,482 |
| Total Unusual Items | - | $0 | $11,262 |
| Total Unusual Items Excluding Goodwill | - | $0 | $11,262 |
| Preferred Stock Dividends | - | $15,445 | $109,262 |
| Other Special Charges | - | - | $-11,262 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-970,678 | $-738,620 | $-1,023,032 |
| Total Assets | $2,851 | $75,175 | $130,932 |
| Total Non Current Assets | $1,121 | $49,360 | $128,266 |
| Current Assets | $1,730 | $25,815 | $2,666 |
| Other Current Assets | $-337 | - | - |
| Inventory | $0 | $23,846 | $0 |
| Receivables | $98 | $0 | $0 |
| Accounts Receivable | $98 | $0 | $0 |
| Cash Cash Equivalents And Short Term Investments | $1,969 | $1,969 | $1,056 |
| Cash And Cash Equivalents | $1,969 | $1,969 | $1,056 |
| Cash Financial | $1,969 | $1,969 | $1,056 |
| Prepaid Assets | - | $0 | $1,610 |
| Debt | |||
| Net Debt | $52,187 | $52,187 | $238,655 |
| Total Debt | $54,156 | $54,156 | $239,711 |
| Current Debt And Capital Lease Obligation | $54,156 | - | $239,711 |
| Current Debt | $54,156 | - | $239,711 |
| Long Term Debt And Capital Lease Obligation | - | $54,156 | - |
| Long Term Debt | - | $54,156 | - |
| Other Current Borrowings | - | - | $239,711 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $973,529 | $813,795 | $1,153,964 |
| Total Non Current Liabilities Net Minority Interest | $0 | $54,156 | $0 |
| Current Liabilities | $973,529 | $759,639 | $1,153,964 |
| Current Notes Payable | $54,156 | $0 | - |
| Payables And Accrued Expenses | $919,373 | $759,639 | $914,253 |
| Interest Payable | $5,176 | $1,836 | $242,280 |
| Payables | $914,197 | $757,803 | $671,973 |
| Other Payable | $3,450 | $3,450 | $3,450 |
| Dividends Payable | $0 | $2,062 | $7,816 |
| Accounts Payable | $474,823 | $516,890 | $526,638 |
| Equity | |||
| Common Stock Equity | $-1,022,778 | $-825,920 | $-1,275,132 |
| Preferred Stock Equity | $52,100 | $87,300 | $252,100 |
| Total Equity Gross Minority Interest | $-970,678 | $-738,620 | $-1,023,032 |
| Stockholders Equity | $-970,678 | $-738,620 | $-1,023,032 |
| Retained Earnings | $-11,692,515 | $-11,459,050 | $-10,882,188 |
| Other | |||
| Ordinary Shares Number | $2,917,899,124 | $2,743,575,314 | $1,782,073,799 |
| Share Issued | $2,917,899,124 | $2,743,575,314 | $1,782,073,799 |
| Tangible Book Value | $-1,022,778 | $-825,920 | $-1,275,132 |
| Invested Capital | $-968,622 | $-771,764 | $-1,035,421 |
| Working Capital | $-971,799 | $-733,824 | $-1,151,298 |
| Total Capitalization | $-970,678 | $-684,464 | $-1,023,032 |
| Additional Paid In Capital | $7,751,839 | $7,889,555 | $7,824,982 |
| Capital Stock | $2,969,998 | $2,830,875 | $2,034,174 |
| Common Stock | $2,917,898 | $2,743,575 | $1,782,074 |
| Preferred Stock | $52,100 | $87,300 | $252,100 |
| Current Accrued Expenses | $5,176 | $1,836 | $242,280 |
| Dueto Related Parties Current | $435,924 | $235,401 | $134,069 |
| Net PPE | $1,121 | $49,360 | $128,266 |
| Accumulated Depreciation | $-235,596 | $-187,357 | $-108,451 |
| Gross PPE | $236,717 | $236,717 | $236,717 |
| Other Properties | $236,717 | $236,717 | $236,717 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-10,337 | $-153,243 | $-445,842 |
| Operating Activities | |||
| Operating Cash Flow | $-10,337 | $-153,243 | $-405,615 |
| Cash Flow From Continuing Operating Activities | $-10,337 | $-153,243 | $-405,615 |
| Operating Gains Losses | - | - | $-11,262 |
| Investing Activities | |||
| Investing Cash Flow | $0 | $0 | $-40,227 |
| Cash Flow From Continuing Investing Activities | $0 | $0 | $-40,227 |
| Capital Expenditure | - | - | $-40,227 |
| Financing Activities | |||
| Issuance Of Capital Stock | $0 | $50,000 | $426,250 |
| Financing Cash Flow | $10,000 | $154,156 | $423,590 |
| Cash Flow From Continuing Financing Activities | $10,000 | $154,156 | $423,590 |
| Net Other Financing Charges | $10,000 | $50,000 | $-13,922 |
| Net Preferred Stock Issuance | $0 | $50,000 | $426,250 |
| Preferred Stock Issuance | $0 | $50,000 | $426,250 |
| Other | |||
| Repayment Of Debt | $0 | $-5,844 | $0 |
| Issuance Of Debt | $0 | $60,000 | $11,262 |
| Interest Paid Supplemental Data | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 |
| End Cash Position | $1,632 | $1,969 | $1,056 |
| Beginning Cash Position | $1,969 | $1,056 | $23,308 |
| Changes In Cash | $-337 | $913 | $-22,252 |
| Net Issuance Payments Of Debt | $0 | $54,156 | $11,262 |
| Net Long Term Debt Issuance | $0 | $54,156 | $11,262 |
| Long Term Debt Payments | $0 | $-5,844 | $0 |
| Long Term Debt Issuance | $0 | $60,000 | $11,262 |
| Net PPE Purchase And Sale | $0 | $0 | $-40,227 |
| Purchase Of PPE | $0 | $0 | $-40,227 |
| Change In Working Capital | $156,279 | $131,112 | $160,788 |
| Change In Payables And Accrued Expense | $151,141 | $153,348 | $160,763 |
| Change In Accrued Expense | $3,340 | $61,764 | $60,605 |
| Change In Interest Payable | $3,340 | $61,764 | $60,605 |
| Change In Payable | $147,801 | $91,584 | $100,158 |
| Change In Account Payable | $147,801 | $91,584 | $100,158 |
| Change In Prepaid Assets | $0 | $1,610 | $0 |
| Change In Inventory | $5,236 | $-23,846 | $0 |
| Change In Receivables | $-98 | $0 | $25 |
| Changes In Account Receivables | $-98 | $0 | $25 |
| Asset Impairment Charge | $18,610 | $0 | - |
| Depreciation Amortization Depletion | $48,239 | $78,906 | $77,785 |
| Depreciation And Amortization | $48,239 | $78,906 | $77,785 |
| Depreciation | $48,239 | $78,906 | $77,785 |
| Net Income From Continuing Operations | $-233,465 | $-561,417 | $-632,926 |
| Other Non Cash Items | - | $198,156 | - |
| Net Short Term Debt Issuance | - | - | $0 |
| Short Term Debt Payments | - | - | $0 |
Fetched: 2026-02-02